Precision Cardiology Market To Generate $2,998.4 Million Revenue by 2030, says P&S Intelligence

NEW YORK, April 19, 2022 /PRNewswire/ -- The precision cardiology market size stood at $1,011.5 million in 2021, and it is predicted to grow at a 12.8% CAGR during 2021–2030, to reach $2,998.4 million by 2030. The market expansion is supported by the reducing cost of sequencing studies and rising awareness of the early screening of cardiovascular diseases (CVDs), which continue to rise in incidence. For example, according to the World Health Organization (WHO), around 17.9 million individuals died from CVDs alone in 2019, accounting for approximately 31% of the total deaths globally.

Players in the precision cardiology market are highly interested in product launches and approvals, to achieve a competitive advantage. In January 2022, GENinCode, an emerging predictive genetics company, filed a pre-submission application to the Food and Drug Administration (FDA) for its Cardio inCode-SCORE. It is an IVD test that evaluates an individual's combined genetic and clinical risks, for preventing and predicting CVDs. Other major players in the market include Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc., Fulgent Genetics Inc., Exact Sciences Corporation, Eurofins Scientific, CENTOGENE N.V., and ARUP Laboratories.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/precision-cardiology-market/report-sample

Key Findings of Precision Cardiology Market Report

• The burgeoning senior population, inactive lifestyle, unhealthy eating patterns, diabetes, tobacco consumption, and family history of CVDs lead to the high prevalence of CVDs.
• For example, as per the Centers for Disease Control and Prevention (CDC), more than 600,000 individuals in the U.S. die from heart illnesses per year. Moreover, as per the Heart Foundation, approximately 4 million Australians are suffering from CVDs. Furthermore, according to the European Heart Network, 3.9 million deaths happen in Europe each year due to these conditions.
• North America carried the highest revenue percentage in the precision cardiology market in the past. This is ascribed to the presence of prominent market players in the U.S. and the rising adoption of advanced services and products in clinical and research settings.
• Diagnostic and hospital laboratories stand at the forefront of the usage of advanced testing methods for CVDs. These laboratories boast expertise in pathology and practice enhanced diagnostics.
• The usage of precision diagnostics for cardiomyopathy is expected to generate revenue of more than $800 million by 2030. The American College of Cardiology reported that the worldwide prevalence of alcoholic cardiomyopathy alone was more than 700,000 cases in 2019.
• In the coming years, the usage of non-blood samples will witness the faster growth as they are easier to obtain. Moreover, blood drawing is an invasive process, and many people have a fear of needles. As a result, the usage of buccal swabs and saliva for CVD testing is gaining precedence.

Browse detailed report on Precision Cardiology Market - Global Industry Revenue Estimation and Demand Forecast to 2030

In 2021, the precision cardiology market was dominated by the service offering, holding around 80% share. This is mainly attributed to the rising focus on the adoption of precision medicine in clinical settings. This is majorly credited to the increasing worldwide burden of CVDs, which is driving the precision diagnostic service demand.

The sequencing technique accounted for the highest revenue, of above $600 million, in 2021. This classification is predicted to display the same trend in the near future owing to the clinical benefits of this technique, including higher precision, broader coverage, low cost, and scalability.

Precision Cardiology Market Segmentation Analysis

By Offering

• Service
• Product

By Sample

• Blood
• Non-Blood
• Saliva
• Buccal swabs

By Technology

• Sequencing
• Next-generation sequencing (NGS)
• Sanger sequencing
• Polymerase Chain Reaction (PCR)
• Microarray

By Application

• Cardiomyopathy
• Arrhythmia
• Aortopathy and Vascular Diseases
• Familial Hypercholesterolemia (FH)
• Congenital Heart Defects and Syndromes
• Others

By End User

• Hospitals and Diagnostic Laboratories
• Academic and Research Institutes

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Italy
• France
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• Saudi Arabia
• South Africa

Browse Other Report Published by P&S Intelligence

Global In Vitro Diagnostic Market Present Scenario And The Growth Prospects 2030

During the historical period (2014–2019), the in vitro diagnostic market was dominated by North America, which will continue to hold the largest share till 2030. Driven by extensive research and development (R&D), IVD processes and technologies are undergoing widespread technological advancements.

Global Diagnostic Imaging Systems Market Present Scenario And The Growth Prospects 2030

Globally, North America contributed the highest revenue to the diagnostic imaging systems market in the years gone by. This was because of the high incidence of chronic diseases, existence of several hospitals and diagnostic centers, and the high healthcare expenditure of the regional countries.

Global Precision Medicine Market Present Scenario And The Growth Prospects 2030

Geographically, the precision medicine market is expected to demonstrate the fastest growth in the Asia-Pacific region during the forecast period.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]   
Web: https://www.psmarketresearch.com   
Follow Us: LinkedIn Twitter

SOURCE P&S Intelligence